Skip to main content
Equibles
XTNT logo

XTNT · Xtant Medical Holdings, Inc. · Webcasts, Transcripts & Audio

Track XTNT — free

Use XTNT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XTNT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.35 0.00 (-0.25%) At close · Oct 1
Rebalance outlook locked
Market Cap
$52.02M
Shares
140.29M
Volume · Oct 1 36.84K Avg daily vol (3M) 1.69M

Xtant Medical Holdings, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Xtant Medical Holdings, Inc. (XTNT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲5% $14.46M −$2.35M '22 Q3 22-11-03 ▲9.3% $15.27M −$2.21M '22 Q4 23-03-07 ▲38.5% $17.94M −$2.08M '23 Q1 23-05-04 ▲32.4% $20.23M −$2.19M '23 Q2 23-08-01 ▲73% $25.02M $9.23M '23 Q3 23-11-09 ▲84.1% $28.11M −$4.30M '23 Q4 23-12-31 ▲55.3% $27.87M −$4.40M '24 Q1 24-04-01 ▲48% $29.94M −$3.86M '24 Q2 24-08-08 ▲11.7% $27.94M −$5.02M '24 Q3 24-11-12 ▲12.1% $31.51M −$3.16M '24 Q4 25-03-06 ▲18% $32.90M $58,000 '25 Q1 25-05-12 ▲18.3% $35.41M $3.55M '25 Q2 25-08-12 ▲19% $33.26M $1.31M '25 Q3 25-11-11 ▲2.7% $32.36M $57,000 '25 Q4 26-03-31 ▼36.5% $20.88M −$3.09M '26 Q1 26-05-13 LATEST ▼35% $23.03M −$9.41M '26 Q2 26-08-11
Earnings call
FY26 · Q2
2026-08-11
Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call
Revenue
$23.03M
▼ 35% YoY
Diluted EPS
$-0.07
▼ 450% YoY
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
Confident tone Trivium Shaped product launch Companion Spine divestiture and balance sheet HEMOBLAST Bellows / Dilon Technologies license
Revenue
$20.88M
▼ 36.5% YoY
Diluted EPS
$-0.02
Gross margin
57.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript
Positive tone Companion Spine divestiture and strategic refocus Hardware segment outlook Self-sustainability and financial discipline
Revenue
$32.36M*
▲ 2.7% YoY
Gross margin
54.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Xtant Medical Holdings, Inc. (XTNT) Q3 2025 Earnings Call Transcript
Confident tone New product launches and innovation Amniotic membrane reimbursement landscape Pending Coflex/Cofix divestiture to Companion Spine
Revenue
$33.26M
▲ 19% YoY
Diluted EPS
$0.01
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript
Confident tone Biologics growth and new product launches Sale of non-core COFLEX/Paradigm OUS assets Gross margin outlook
Revenue
$35.41M
▲ 18.3% YoY
Diluted EPS
$0.02
Gross margin
68.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Xtant Medical Holdings, Inc. (XTNT) Q1 2025 Earnings Call Transcript
Confident tone Biologics vertical integration and new product launches Revenue growth and guidance Cash flow and capital needs
Revenue
$32.90M
▲ 18% YoY
Diluted EPS
$0.00
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-06
Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript
Positive tone Gross margin pressure Biologics business and vertical integration Cost-cutting and self-sustainability
Revenue
$31.51M*
▲ 12.1% YoY
Gross margin
50.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Call Transcript
Confident tone New Product Launches Profitability and Adjusted EBITDA In-House Biologics Manufacturing
Revenue
$27.94M
▲ 11.7% YoY
Diluted EPS
$-0.04
▼ 157.1% YoY
Gross margin
58.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call
Revenue
$29.94M
▲ 48% YoY
Diluted EPS
$-0.03
Gross margin
62.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-01
Xtant Medical Holdings, Inc. (XTNT) Q1 2024 Earnings Call Transcript
Confident tone Distribution & Contract Access Profitability & Gross Margin New Product Introductions
Revenue
$27.87M
▲ 55.3% YoY
Diluted EPS
$-0.03
Gross margin
62.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Xtant Medical Holdings, Inc. (XTNT) Q4 2023 Earnings Call Transcript
Revenue
$28.11M*
▲ 84.1% YoY
Gross margin
61.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Xtant Medical Holdings, Inc. (XTNT) Q3 2023 Earnings Call Transcript
Revenue
$25.02M
▲ 73% YoY
Diluted EPS
$0.07
Gross margin
61.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Xtant Medical Holdings, Inc. (XTNT) Q2 2023 Earnings Call Transcript
Revenue
$20.23M
▲ 32.4% YoY
Diluted EPS
$-0.02
Gross margin
61.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Xtant Medical Holdings, Inc. (XTNT) Q1 2023 Earnings Call Transcript
Revenue
$17.94M
▲ 38.5% YoY
Diluted EPS
$-0.02
Gross margin
58.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Xtant Medical Holdings, Inc. (XTNT) Q4 2022 Earnings Call Transcript
Revenue
$15.27M*
▲ 9.3% YoY
Gross margin
54.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Xtant Medical Holdings, Inc. (XTNT) Q3 2022 Earnings Call Transcript
Revenue
$14.46M
▲ 5% YoY
Diluted EPS
$-0.03
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Xtant Medical Holdings, Inc. (XTNT) Q2 2022 Earnings Call Transcript
Revenue
$15.28M
▲ 2% YoY
Diluted EPS
$-0.02
Gross margin
54.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Xtant Medical Holdings, Inc. (XTNT) Q1 2022 Earnings Call Transcript
Revenue
$12.96M
▲ 3.3% YoY
Diluted EPS
$-0.03
Gross margin
58.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
Xtant Medical Holdings, Inc. (XTNT) Q4 2021 Earnings Call
Revenue
$13.97M*
▼ 0.3% YoY
Gross margin
55.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Xtant Medical Holdings, Inc. (XTNT) Q3 2021 Earnings Call
Revenue
$13.78M
▼ 1.7% YoY
Diluted EPS
$-0.02
Gross margin
52.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Xtant Medical Holdings, Inc. (XTNT) Q2 2021 Earnings Call
Revenue
$14.97M
▲ 42.2% YoY
Diluted EPS
$-0.01
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Xtant Medical Holdings, Inc. (XTNT) Q1 2021 Earnings Call
Revenue
$12.54M
▼ 15.1% YoY
Diluted EPS
$0.00
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Xtant Medical Holdings, Inc. (XTNT) Q4 2020 Earnings Call Transcript
Revenue
$14.02M*
▼ 17.4% YoY
Gross margin
64.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-01
Xtant Medical Holdings, Inc. (XTNT) Q3 2020 Earnings Call Transcript
Revenue
$14.02M
▼ 10.8% YoY
Diluted EPS
$-0.10
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-03
Xtant Medical Holdings, Inc. (XTNT) Q2 2020 Earnings Call Transcript
Revenue
$10.53M
▼ 31.1% YoY
Diluted EPS
$-0.19
Gross margin
62.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Xtant Medical Holdings, Inc. (XTNT) Q1 2020 Earnings Call Transcript
Revenue
$14.78M
▼ 11.7% YoY
Diluted EPS
$-0.19
Gross margin
65.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Xtant Medical Holdings, Inc. (XTNT) Q4 2019 Earnings Call
Revenue
$16.96M*
▼ 7.1% YoY
Gross margin
67.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 1453593 CUSIP 98420P308 13F (30d) 2 filings 2 filers Visit website Investor relations